NCT05911776 is a Phase 4 clinical trial of Nasal packing Dexmedetomidine in Nasal Packing, sponsored by Kafrelsheikh University.

Who is sponsoring NCT05911776?

NCT05911776 is sponsored by Kafrelsheikh University.

What drugs are being tested in NCT05911776?

Interventions in NCT05911776: Nasal packing Dexmedetomidine, Intravenous Dexmedetomidine.

What condition does NCT05911776 study?

NCT05911776 studies Nasal Packing, Dexmedetomidine, Turbinate.

Is NCT05911776 still recruiting?

NCT05911776 is currently completed. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT05911776

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries

Completed Phase 4 Last updated 12 March 2024

What this trial tests

Phase 4 trial testing Nasal packing Dexmedetomidine in Nasal Packing in 60 participants. Completed in 27 February 2024.

Timeline

30 June 2023

Primary endpoint
27 February 2024

27 February 2024

Quick facts

Lead sponsor	Kafrelsheikh University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	30 June 2023
Primary completion	27 February 2024
Estimated completion	27 February 2024
Sites	1 location across Egypt

Drugs / interventions tested

Nasal packing Dexmedetomidine — full drug profile →
Intravenous Dexmedetomidine — full drug profile →

Conditions studied

Nasal Packing — all drugs for Nasal Packing →
Dexmedetomidine — all drugs for Dexmedetomidine →
Turbinate — all drugs for Turbinate →

Sponsor

Kafrelsheikh University

Who can join

Adults 18 to 65, any sex, with Nasal Packing or Dexmedetomidine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing of nasal packing DEX and IV DEX for controlling the intraoperative bleeding after turbinate surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kafrelsheikh University trials

Trials by the same sponsor.

NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05911776 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05911776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing